Gentex slides 3% as Goldman trims target days after upbeat Q1 guidance raise
Gentex shares fell about 3% on April 29, 2026, as investors digested a fresh analyst price-target cut early in the week. The move comes days after Gentex reported Q1 2026 results and raised full-year 2026 revenue guidance, leaving the stock vulnerable to profit-taking.
1. What’s moving the stock today
Gentex (GNTX) is down about 3% in Wednesday trading (April 29, 2026), extending a post-earnings fade as the market focuses on incremental negative revisions. The key near-term catalyst is a newly published analyst action from earlier this week: Goldman Sachs lowered its price target on Gentex to $24, which is pressuring sentiment even after the company’s latest quarterly update.
2. The backdrop: earnings were solid, but the stock is still resetting
Gentex reported first-quarter 2026 results on Friday, April 24, including revenue of $675.4 million and adjusted EPS of $0.48, alongside an updated 2026 revenue outlook of $2.65 billion to $2.75 billion. Despite the guidance raise, investors appear to be reassessing valuation and end-market assumptions, which can drive a pullback when the next wave of analyst notes turns more cautious on the forward setup.
3. What investors are watching next
The next read-through for GNTX is whether demand and production assumptions hold up—particularly around tariff-related uncertainty and regional softness that management has highlighted as a risk factor in filings. Traders will also watch for additional analyst revisions following the Q1 call, plus any commentary on the pace of share repurchases and how quickly the company can convert guidance optimism into sustained earnings momentum.